Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Intern Med. 1995 Apr 15;122(8):569-72.

Late relapses in patients successfully treated for thrombotic thrombocytopenic purpura. Canadian Apheresis Group.

Author information

  • 1University of Toronto, Canada.

Abstract

OBJECTIVE:

To determine the incidence and timing of relapses in patients who have recovered from an acute episode of thrombotic thrombocytopenic purpura.

DESIGN:

Clinical follow-up for 3 to 10 years.

SETTING:

General community outpatient study; patients who had relapse were hospitalized.

PARTICIPANTS:

63 of 72 surviving patients who had participated in a randomized study that compared plasma exchange and plasma infusion as treatments for thrombotic thrombocytopenic purpura and for whom continued clinical follow-up was obtained.

OUTCOME MEASURES:

Recurrence of thrombotic thrombocytopenic purpura as defined by a decrease in platelet count to less than 100 x 10(9)/L and by the onset of microangiopathic hemolytic anemia as identified by erythrocyte fragmentation in a peripheral blood film.

RESULTS:

37 of the 63 patients have not had recurrence of thrombotic thrombocytopenic purpura and have remained completely well; 6 patients have not had recurrence but have developed other medical problems; 3 patients have not had recurrence but have residual neurologic defects from the original episode; and 17 patients have had one or more recurrences, occurring 7 months to 8 years after the original episode. As determined by Kaplan-Meier analysis, the projected recurrence rate after 10 years in all surviving patients is 36% (95% CI, 23% to 59%).

CONCLUSIONS:

More than one third of patients who survive an acute episode of thrombotic thrombocytopenic purpura will have at least one relapse during the following 10 years.

PMID:
7887549
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Support Center